Read this company snapshot
Daily valuation snapshot
Biofrontera Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.97
- Market capitalization (USD)
- $14,406,788.23
- Price / earnings (TTM)
- Not reported
- Price / book
- 2.42
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BFRI in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BFRI in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BFRI with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.97 |
| Market capitalization (USD) | $14,406,788.23 |
| Price / earnings (TTM) | Not reported |
| Price / book | 2.42 |
No matching rows. Clear the filter to see all records.
Read BFRI's valuation metrics
Company size
Biofrontera Inc. Common Stock's recorded market capitalization is $14,406,788.23. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
BFRI's recorded price-to-book ratio is 2.42. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Biofrontera Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about BFRI. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow BFRI's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.